Netspot Approval History
- FDA approved: Yes (First approved June 1st, 2016)
- Brand name: Netspot
- Generic name: gallium Ga 68 dotatate
- Dosage form: Injection
- Company: Advanced Accelerator Applications USA, Inc.
- Treatment for: Diagnosis and Investigation
Netspot (gallium Ga 68 dotatate) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors
Development History and FDA Approval Process for Netspot
|Jun 1, 2016||FDA Approves Netspot (gallium Ga 68 dotatate) Imaging Agent to Detect Rare Neuroendocrine Tumors|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.